Company profile · free preview
Becton, Dickinson and Company
BDX · NYSE · Healthcare · Updated 11/14/2026
Revenue
$21.8B
Fiscal 2025
Net income
$1.7B
Fiscal 2025
Free cash flow
—
Fiscal 2025
Net cash / (debt)
—
Fiscal 2025
Five-year financials
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $21.8B | $20.2B | $19.4B | $18.9B | $20.2B |
| Net income | $1.7B | $1.7B | $1.5B | $1.8B | $2.1B |
| Diluted EPS | — | — | — | — | — |
| Operating cash flow | — | — | — | — | $4.6B |
| Free cash flow | — | — | — | — | $3.4B |
| Cash | $641.0M | $1.7B | $1.4B | $1.0B | $2.3B |
| Total debt | — | — | — | — | — |
Financial trends
Historical · FY2021–FY2025
Source: Reported annual filings (10-K / 20-F) and provider data. Fiscal years as reported; margins are calculated from the reported figures shown.
Want the story behind these numbers? Ask Osiris anything about Becton, Dickinson and Company's filings — free.
Create free accountBecton, Dickinson and Company return on capital (fiscal 2025)
ROIC
5.1%
Return on capital
4.9%
Return on equity
6.5%
Return on assets
3.0%
Gross margin
45.4%
Operating margin
13.7%
Net debt / EBITDA
3.68x
Becton, Dickinson and Company insider buying and selling
Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-11-05 | Polen Thomas E Jr | Sale | 2,993 | $210.00 |
| 2026-10-26 | Feld Michael | Sale | 76 | $198.13 |
| 2026-09-28 | Feld Michael | Sale | 76 | $183.70 |
| 2026-08-26 | Feld Michael | Sale | 165 | $188.49 |
SEC filings
No filings stored yet.
Ask anything about Becton, Dickinson and Company's filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching free